Author

Luzie A. Gottwald

Observed name: Luzie Gottwald

Institution: Vivantes Klinikum

Observed institutions: Yale University, Humboldt-Universität zu Berlin, Vivantes Klinikum, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Charité – Universitätsmedizin Berlin

ORCID: 0000-0003-4594-0410

Observed ORCID: 0000-0003-4594-0410

OpenAlex ID: A5016217751

MR Imaging Biomarkers for the Prediction of Outcome after Radiofrequency Ablation of Hepatocellular Carcinoma: Qualitative and Quantitative Assessments of the Liver Imaging Reporting and Data System and Radiomic Features

2022 · Alexandra Petukhova-Greenstein, Tal Zeevi, et al. · Journal of Vascular and Interventional Radiology · 16

Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model

2022 · Antonia M. Berz, Jessica G. Santana, et al. · Journal of Vascular and Interventional Radiology · 16

MR Imaging–Based In Vivo Macrophage Imaging to Monitor Immune Response after Radiofrequency Ablation of the Liver

2022 · Jessica G. Santana, Alexandra Petukhova-Greenstein, et al. · Journal of Vascular and Interventional Radiology · 8

Decision-Tree Models Indicative of Microvascular Invasion on MRI Predict Survival in Patients with Hepatocellular Carcinoma Following Tumor Ablation

2024 · Robin Schmidt, Charlie Hamm, et al. · Journal of Hepatocellular Carcinoma · 3

Works count: 4

Citation count: 43

H-index: 3

I10-index: 2